• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低分子量肝素(CY 216)与低剂量标准肝素对实验性静脉血栓形成影响的比较研究

Comparative study on the effects of a low molecular weight heparin (CY 216) and standard heparin in low dosage on experimental venous thrombosis.

作者信息

Doutremepuich C, Bousquet F, Gestreau G L, Toulemonde F, Bayrou B

出版信息

Haemostasis. 1987;17(4):201-5. doi: 10.1159/000215744.

DOI:10.1159/000215744
PMID:3623263
Abstract

In a venous thrombosis model in the rat obtained by ligation of the inferior vena cava, the effects of standard heparin and CY 216, a low molecular weight heparin fraction, are compared. At a dosage of less than 2 mg/kg b.w. CY 216 is an effective antithrombotic, whereas standard heparin is not.

摘要

在通过结扎大鼠下腔静脉建立的静脉血栓形成模型中,比较了标准肝素和低分子量肝素组分CY 216的效果。在剂量低于2毫克/千克体重时,CY 216是一种有效的抗血栓药物,而标准肝素则不是。

相似文献

1
Comparative study on the effects of a low molecular weight heparin (CY 216) and standard heparin in low dosage on experimental venous thrombosis.低分子量肝素(CY 216)与低剂量标准肝素对实验性静脉血栓形成影响的比较研究
Haemostasis. 1987;17(4):201-5. doi: 10.1159/000215744.
2
Combinations of low doses of unfractionated heparin and of low-molecular-weight heparin prevent experimental venous thrombosis.
Pathophysiol Haemost Thromb. 2005;34(6):263-8. doi: 10.1159/000093105.
3
Effects of heparin oligosaccharides with high affinity for antithrombin III in experimental venous thrombosis.对抗凝血酶III具有高亲和力的肝素寡糖在实验性静脉血栓形成中的作用
Thromb Haemost. 1982 Jun 28;47(3):244-8.
4
Long-term intraperitoneal application of low molecular weight heparin in a continuous ambulatory peritoneal dialysis patient with deep vein thrombosis.低分子量肝素长期腹腔内应用于一名患有深静脉血栓形成的持续性非卧床腹膜透析患者。
Nephron. 1986;42(1):83-4. doi: 10.1159/000183639.
5
A comparative study of prothrombinase and thrombin inhibitors in a novel rabbit model of non-occlusive deep vein thrombosis.在一种新型非闭塞性深静脉血栓形成兔模型中对凝血酶原酶和凝血酶抑制剂的比较研究。
Thromb Haemost. 1994 Mar;71(3):357-62.
6
Comparison of the antithrombotic and haemorrhagic effects of heparin and a new low molecular weight heparin in rats.
Haemostasis. 1985;15(5):324-30. doi: 10.1159/000215167.
7
Antithrombotic potencies of heparins in relation to their antifactor Xa and antithrombin activities: an experimental study in two models of thrombosis in the rabbit.
Br J Haematol. 1990 Sep;76(1):94-100. doi: 10.1111/j.1365-2141.1990.tb07842.x.
8
In vivo neutralization of low-molecular weight heparin fraction CY 216 by protamine.
Semin Thromb Hemost. 1985 Jul;11(3):318-22. doi: 10.1055/s-2007-1004385.
9
Influence of heparin and a low molecular weight heparin fraction of the leukocytes in an experimental venous thrombosis model.肝素及一种低分子量肝素组分对实验性静脉血栓形成模型中白细胞的影响。
J Leukoc Biol. 1987 Dec;42(6):628-31. doi: 10.1002/jlb.42.6.628.
10
Relative efficacy of heparin and related glycosaminoglycans as antithrombotic drugs.肝素及相关糖胺聚糖作为抗血栓药物的相对疗效。
Ann N Y Acad Sci. 1989;556:313-22. doi: 10.1111/j.1749-6632.1989.tb22513.x.